A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ranjana H. Advani Branimir Ivan Sikic |
| Publication date | October 1, 2005 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |